KGK Synergize Inc. (KGK) is a biotechnology company that specializes in nutraceutical and functional food research and development. Currently with a staff of over twenty employees, the company operates two divisions: 1) a fast growing contract research organization (CRO) for third parties 2) an in-house nutraceutical product development (NPD) division. The Company’s primary focus continues to be on the development and commercialization of proprietary nutraceutical supplements and food ingredients from its own research for the prevention or treatment of medical conditions and/or major diseases. KGK also continues to conduct a growing and profitable business of independent scientific research on nutraceutical, biotechnology and pharmaceutical products for other established companies. In addition, the Company also maintains a wholly owned subsidiary, KGK Synergize USA Inc., which was recently established to give KGK better access to the U.S. nutraceutical market.

The CRO division offers a wide range of research services to the client from pre-clinical to clinical trials, data analysis and consultation. KGK can assist the client with protocol development and direct them as to the most beneficial studies to help them meet their objectives. KGK is dedicated to providing clients with top quality service and is both ISO 9001:2000 and GLP certified.

The NPD division experiments with new natural compounds for their therapeutic values. It implements various screening techniques to develop nutraceutical and functional food products to the point where they are ready to manufacture and market. This division currently holds many issued and pending patents in the areas of anti-cancer, cardiovascular, diabetes and anti-inflammatory.

Products:

Sytrinol^R is a proprietary patented composition consisting of polymethoxylated flavones and tocotrienols, specially formulated for the prevention of atherosclerosis and hypercholesterolemia. This product is currently available for distribution through Proprietary Nutritionals Inc.

Additional products with Intellectual Property protection in the pipeline available for licensing are in the areas of anti-cancer, cardiovascular, diabetes and anti-inflammatory.

Facilities:

The corporate headquarters is located at Suite 1440, One London Place, 255 Queens Ave. with the laboratory located at Room 128, Health Services Building, LHSC South Street Campus, 100 Waterloo St., both in London, ON.

Opportunities:

KGK Synergize Inc. invites inquiries from companies and other organizations that might wish to make use of its comprehensive range of testing services. We also welcome the opportunity to discuss patent licensing opportunities.